Trials / Conditions / Eye Disorders Congenital

Eye Disorders Congenital

10 registered clinical trials studyying Eye Disorders Congenital — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) NCT06891443	Laboratoires Thea	Phase 3
Recruiting	Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH NCT06627179	Laboratoires Thea	Phase 2
Terminated	Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon NCT05176717	Laboratoires Thea	Phase 2 / Phase 3
Terminated	Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in E NCT05158296	Laboratoires Thea	Phase 2 / Phase 3
Unknown	An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerabil NCT04855045	ProQR Therapeutics	Phase 2 / Phase 3
Unknown	Single Ascending Dose Study in Participants With LCA10 NCT03872479	Editas Medicine, Inc.	Phase 1 / Phase 2
Terminated	Extension Study to Study PQ-110-001 (NCT03140969) NCT03913130	Laboratoires Thea	Phase 1 / Phase 2
Active Not Recruiting	A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in NCT03913143	ProQR Therapeutics	Phase 2 / Phase 3
Completed	Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the US NCT03780257	ProQR Therapeutics	Phase 1 / Phase 2
Completed	Natural History Study of CEP290-Related Retinal Degeneration NCT03396042	Editas Medicine, Inc.	—